Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
21,713,346
-
Shares change
-
+887,778
-
Total reported value, excl. options
-
$1,020,171,713
-
Value change
-
+$29,265,071
-
Put/Call ratio
-
153%
-
Number of buys
-
90
-
Number of sells
-
-95
-
Price
-
$46.99
Significant Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2014
222 filings reported holding LGND - LIGAND PHARMACEUTICALS INC - Common Stock as of Q3 2014.
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,713,346 shares
.
Largest 10 shareholders include RS INVESTMENT MANAGEMENT CO LLC (1,493,635 shares), FMR LLC (1,413,968 shares), Knott David M (1,249,766 shares), BlackRock Fund Advisors (1,240,648 shares), BVF INC/IL (1,108,763 shares), BLAIR WILLIAM & CO/IL (1,055,321 shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (936,825 shares), VANGUARD GROUP INC (920,000 shares), Invesco Ltd. (800,045 shares), and State Street Corp (647,311 shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.